Categories: Health

Financire de Tubize – 2025 half-year financial report

 | Source: Financière de Tubize SA

Half-year financial report 2025
Regulated information 2 August 2025

The board of directors of Financière de Tubize has established the 2025 half-year report. This report is available on the website www.financiere-tubize.be.

  • Profit for the first half of 2025: € 95.6 million (€ 92.9 million in 2024, + 2.8%),
  • Dividend received from UCB: € 98.1 million (€ 1.39 per share, an increase of 2.2% compared to the previous year),
  • 2024 Dividend paid to Financière de Tubize’s shareholders in 2025 of € 46.3 million (€ 1.04 per share, an increase of 7.22% compared to the previous year),
  • Acquisition, in 2025, of 24,487 UCB shares, for a total amount of € 4.37 million, at an average price of € 178.3. Our stake in UCB has increased from 36.27% on 31 December 2024 to 36,28% on 30 June 2025,
  • Decrease of outstanding bank borrowings from € 41.3 million at 31 December 2024 to € nil at 30 June 2025.
GlobeNews Wire

Recent Posts

Both Leading Independent Proxy Advisors Recommend Aterian Stockholders Vote for the Asset Sale

July 08, 2026 17:30 ET  | Source: Aterian, Inc Glass Lewis cites structured strategic reviewISS…

56 minutes ago

Republic Power Group Limited Regains Compliance with Nasdaq Minimum Bid Price Requirement

July 08, 2026 16:30 ET  | Source: Republic Power Group Limited Singapore, July 08, 2026…

56 minutes ago

Groove Technology Solutions Partners with HPS to Expand Access to Property Technology Solutions

July 08, 2026 16:29 ET  | Source: Groove Technology Solutions Salt Lake City, July 08,…

56 minutes ago

Outliyr’s Independent Spectrometer Tests Find Popular Red Light Therapy Devices Delivering From 67 Percent to Nearly Triple Their Advertised Power

Outliyr's free public database catalogs more than seventy red light therapy panels and other light…

57 minutes ago

Rhythm Pharmaceuticals Announces The New England Journal of Medicine Publication of Phase 3 TRANSCEND Trial Results in Acquired Hypothalamic Obesity

BOSTON, July 08, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage…

57 minutes ago

Range Impact Announces Vin Ferrara, MD, MBA, Has Joined the Company as Vice President, Real Estate

CLEVELAND, OHIO, July 08, 2026 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTC: RNGE) (“Range Impact”…

57 minutes ago